Stockscreener 앱 받기
24.85
2.05%
0.50
Cg Oncology Inc 주식(CGON)의 최신 뉴스
CG Oncology price target lowered to $62 from $63 at BofA - MSN
CG Oncology’s Q2 2025: Clinical Advances and Legal Wins - The Globe and Mail
CG Oncology 2025 Q1 Earnings Net Loss Widens Sharply - AInvest
CG Oncology's Q2 2025: Balancing Burn Rate and Breakthroughs in the Race for Bladder Cancer Innovation - AInvest
Cg Oncology (CGON) Q2 Loss Widens 93% - The Motley Fool
Cg Oncology (CGON) Q2 Loss Widens 93% - Nasdaq
Earnings Flash (CGON) CG Oncology Posts Q2 Net Loss $0.54 a Share, vs. FactSet Est of $0.46 Loss - MarketScreener
CG Oncology reports Q2 EPS (54c), consensus (44c) - TipRanks
How King & Spalding Beat $2B Claim In Biopharma Fight - Law360
Is CG Oncology Inc. a good long term investmentSuperior return velocity - Jammu Links News
Does CG Oncology Inc. stock perform well during market downturnsGet ahead with breakthrough trading ideas - Jammu Links News
What analysts say about CG Oncology Inc. stockInvest confidently with real-time market updates - Jammu Links News
How does CG Oncology Inc. generate profit in a changing economyBreakthrough profit margins - Jammu Links News
CG Oncology, Inc. (CGON) Reports 75.5% Complete Response in Bladder Cancer Trial - MSN
When is CG Oncology Inc. stock expected to show significant growthInvest confidently with real-time data analysis - Jammu Links News
What are the latest earnings results for CG Oncology Inc.Breakthrough investment results - Jammu Links News
Should I hold or sell CG Oncology Inc. stock in 2025Discover stocks with explosive potential - Jammu Links News
How strong is CG Oncology Inc. company’s balance sheetUnlock expert market analysis instantly - Jammu Links News
What is the risk reward ratio of investing in CG Oncology Inc. stockInvest smarter with advanced market data - Jammu Links News
What makes CG Oncology Inc. stock price move sharplyFree Stock Market Query - Jammu Links News
How to interpret RSI for CG Oncology Inc. stockStock Entry Point Planner with Volume Spike - Newser
Applying big data sentiment scoring on CG Oncology Inc.Free Weekly Setup With 3x Return Potential - Newser
CG Oncology Inc. stock trend outlook and recovery pathTrade Safety Matrix for Conservative Traders - Newser
How volatile is CG Oncology Inc. stock compared to the marketAdvanced Screener Report With Low Risk - Jammu Links News
Why is CG Oncology Inc. stock attracting strong analyst attentionRetirement Planning Forecasts Backed By Experts - Jammu Links News
Building trade automation scripts for CG Oncology Inc.Free Pattern Detection for Entry Confirmation - Newser
What recovery options are there for CG Oncology Inc.Swing Gain Strategy with Entry Forecast - Newser
Comparing CG Oncology Inc. in custom built stock radarsShort-Term Bounce Forecast for Oversold Stocks - Newser
New Product Launches: Will They Boost CG Oncology Inc. Stock in 2025Daily Market Momentum and Pressure Analysis - Newser
ANI Pharmaceuticals Challenges Court Verdict on Royalty Payment Agreement - AInvest
Can CG Oncology Inc. stock recover from recent declineSecure Entry Point Finder with Analysis - Newser
11 Best Future Stocks to Buy Now - Insider Monkey
CG Oncology Soars 10.41% Post Legal Win - AInvest
Options Data Show Bullish Bias in CG Oncology Inc.Early Entry Picks Before News Breakout Reviewed - metal.it
CG Oncology wins Delaware jury trial against ANI Pharmaceuticals By Investing.com - Investing.com South Africa
Delaware Superior Court Jury Issues Unanimous Verdict that CG Oncology Owes No Future Royalties or Other Payments to ANI Pharmaceuticals - The Manila Times
CG Oncology Secures Major Legal Victory: Court Rules No 5% Royalties on Promising Bladder Cancer Drug - Stock Titan
Why CG Oncology Inc. stock attracts strong analyst attentionFree Low Risk Equity Screener With Results - Newser
How CG Oncology Inc. stock performs during market volatilityWeekly Setup Summary for Risk Controlled Trades - Newser
Intraday pattern recognizer results for CG Oncology Inc.Free Buy Signal Based on Chart Analysis - Newser
CG Oncology wins Delaware jury trial against ANI Pharmaceuticals - Investing.com
0.24%
3.39%
자본화:
|
볼륨(24시간):